Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Venous thromboembolism in cancer patients: a population-based cohort study

F. I. Mulder, E. Horváth-Puhó, N. van Es, H. W. M. van Laarhoven, L. Pedersen, F. Moik, C. Ay, H. R. Büller, H. T. Sørensen

Blood (2021) 137 (14): 1959–1969.

https://doi.org/10.1182/blood.2020007338

Published: 2021

Includes: Supplemental data

Journal Articles

The Outcome of Hematopoietic Cell Transplantation (HCT) for Myelodysplastic Syndrome (MDS) in Adults ≥65 Years of Age: First Report of the Coverage with Evidence Development (CED) in Medicare Beneficiaries

Ehab Atallah, MD, Tanya L. Pedersen, MPH, Erica D. Warlick, MD, Anne Dircks, BS, CCRP, Daniel Weisdorf, MD, Mary M. Horowitz, MD, MS, J. Douglas Rizzo, MD

Blood (2012) 120 (21): 1983.

https://doi.org/10.1182/blood.V120.21.1983.1983

Published: 2012

Journal Articles

Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era

Blood (2012) 119 (17): 4083–4090.

https://doi.org/10.1182/blood-2012-02-409763

Published: 2012

Journal Articles

Older Adults with Chronic Myelogenous Leukemia (CML), During the Tyrosine Kinase Inhibitor (TKI) Era, Can Be Successfully Treated with Reduced Intensity Conditioning (RIC) Hematopoietic Cell Transplant (HCT) Using Sibling or Unrelated Donors: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis

Erica D Warlick, MD, Brian McClune, DO, Tanya L. Pedersen, MPH, Kwang W Awn, PhD, Joseph H. Antin, MD, Jean-Yves Cahn, MD, Marcos DeLima, MD, Vikas Gupta, MD, FRCP, FRCPath, David I Marks, MD, Donald Bunjes, MD, John F. DiPersio, MD, PhD, Steven Devine, Daniel J. Weisdorf, MD

Blood (2011) 118 (21): 494.

https://doi.org/10.1182/blood.V118.21.494.494

Published: 2011

Journal Articles

Reduced Intensity or Non-Ablative Hematopoietic Cell Transplantation in Older Patients with Non-Hodgkin Lymphoma (NHL): Encouraging Survival for Patients ≥55 Years

Brian McClune, DO, Tanya L. Pedersen, MPH, Kwang W Ahn, PhD, Erica D Warlick, MD, Joseph Pidala, MD, MS, Edmund K Waller, MD PhD, J. Douglas Rizzo, MD MS, Mitchell S. Cairo, MD, Ann Woolfrey, MD, Andrew Artz, MD MS, Hillard M. Lazarus, MD FACP, Daniel J. Weisdorf, MD

Blood (2011) 118 (21): 1015.

https://doi.org/10.1182/blood.V118.21.1015.1015

Published: 2011

Journal Articles

Relationship of Race/Ethnicity and Survival After Single Umbilical Cord Blood Transplantation

Karen K. Ballen, MD, John P. Klein, Ph.D., Tanya L. Pedersen, MPH, Joanne Kurtzberg, MD, Hillard M. Lazarus, MD, FACP, Charles F. LeMaistre, MD, Paulette Mehta, M.D, MPH, Jeanne Palmer, MD, Michelle Setterholm, John R. Wingard, MD, Steven Joffe, MD, MPH, Susan K. Parsons, MD, MRP, Galen E. Switzer, PhD, Stephanie J. Lee, MD, MPH, J. Douglas Rizzo, MD, MS, Navneet S. Majhail, MD, MS, for the Health Policy Working Committee of the CIBMTR

Blood (2010) 116 (21): 224.

https://doi.org/10.1182/blood.V116.21.224.224

Published: 2010

Journal Articles

Practice patterns for evaluation, consent, and care of related donors and recipients at hematopoietic cell transplantation centers in the United States

Paul V. O'Donnell, Tanya L. Pedersen, Dennis L. Confer, J. Douglas Rizzo, Michael A. Pulsipher, David Stroncek, Susan Leitman, Paolo Anderlini

Blood (2010) 115 (24): 5097–5101.

https://doi.org/10.1182/blood-2010-01-262915

Published: 2010

Includes: Supplemental data

Journal Articles

Non-Myeloablative Hematopoietic Stem Cell Transplantation in Older Patients with AML and MDS: Results from the Center for International Blood and Marrow Transplant Research (CIBMTR)

Brian McClune, DO, Daniel J. Weisdorf, MD, John F. DiPersio, MD, PhD, Armand Keating, MD, Tanya L. Pedersen, Gisela Tunes da Silva, PhD., J. Sierra, MD, Martin S. Tallman, MD, Sergio A. Giralt

Blood (2008) 112 (11): 346.

https://doi.org/10.1182/blood.V112.11.346.346

Published: 2008

Journal Articles

HuMax-CD20, a Novel Fully Human Anti-CD20 Monoclonal Antibody: Results of a Phase I/II Trial in Relapsed or Refractory Follicular Non-Hodgkins’s Lymphoma.

A. Hagenbeek, T. Plesner, P. Johnson, L. Pedersen, J. Walewski, A. Hellmann, B. Link, T. Robak, M. Wojtukiewicz, M. Pfreundschuh, M. Kneba, A. Engert, P. Sonneveld, J. Petersen, J. Radford

Blood (2005) 106 (11): 4760.

https://doi.org/10.1182/blood.V106.11.4760.4760

Published: 2005

NARROW

Venous thromboembolism in cancer patients: a population-based cohort study

The Outcome of Hematopoietic Cell Transplantation (HCT) for Myelodysplastic Syndrome (MDS) in Adults ≥65 Years of Age: First Report of the Coverage with Evidence Development (CED) in Medicare Beneficiaries

Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era

Reduced Intensity or Non-Ablative Hematopoietic Cell Transplantation in Older Patients with Non-Hodgkin Lymphoma (NHL): Encouraging Survival for Patients ≥55 Years

Relationship of Race/Ethnicity and Survival After Single Umbilical Cord Blood Transplantation

Practice patterns for evaluation, consent, and care of related donors and recipients at hematopoietic cell transplantation centers in the United States

Non-Myeloablative Hematopoietic Stem Cell Transplantation in Older Patients with AML and MDS: Results from the Center for International Blood and Marrow Transplant Research (CIBMTR)

HuMax-CD20, a Novel Fully Human Anti-CD20 Monoclonal Antibody: Results of a Phase I/II Trial in Relapsed or Refractory Follicular Non-Hodgkins’s Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only